Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth

PURPOSE: To reduce the adverse effects and high frequency of administration of propranolol to treat infantile hemangioma, we first utilized propranolol-loaded liposomes-in-microsphere (PLIM) as a novel topical release system to realize sustained release of propranolol. METHODS: PLIM was developed fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaonan, Zhu, Xiaoshuang, Liu, Dakan, Gong, Yubin, Sun, Jing, Dong, Changxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609781/
https://www.ncbi.nlm.nih.gov/pubmed/29075111
http://dx.doi.org/10.2147/IJN.S137634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609781/
https://www.ncbi.nlm.nih.gov/pubmed/29075111
http://dx.doi.org/10.2147/IJN.S137634

Ejemplares similares